Pediatrix Medical Group, Inc. $MD Stock Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC grew its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 27.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,070,961 shares of the company’s stock after acquiring an additional 452,051 shares during the period. Allspring Global Investments Holdings LLC owned 2.65% of Pediatrix Medical Group worth $53,348,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in the business. Choreo LLC boosted its position in shares of Pediatrix Medical Group by 5.7% during the 3rd quarter. Choreo LLC now owns 8,361 shares of the company’s stock valued at $215,000 after purchasing an additional 448 shares in the last quarter. Nisa Investment Advisors LLC increased its holdings in Pediatrix Medical Group by 3.3% in the third quarter. Nisa Investment Advisors LLC now owns 19,131 shares of the company’s stock worth $492,000 after purchasing an additional 605 shares in the last quarter. Hohimer Wealth Management LLC lifted its stake in Pediatrix Medical Group by 5.4% in the third quarter. Hohimer Wealth Management LLC now owns 12,714 shares of the company’s stock valued at $327,000 after buying an additional 655 shares during the period. State of Wyoming lifted its stake in Pediatrix Medical Group by 4.5% in the third quarter. State of Wyoming now owns 24,525 shares of the company’s stock valued at $631,000 after buying an additional 1,060 shares during the period. Finally, Concurrent Investment Advisors LLC lifted its stake in Pediatrix Medical Group by 4.0% in the second quarter. Concurrent Investment Advisors LLC now owns 28,384 shares of the company’s stock valued at $719,000 after buying an additional 1,087 shares during the period. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Up 0.2%

Shares of NYSE:MD opened at $31.55 on Wednesday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.28 and a current ratio of 1.28. Pediatrix Medical Group, Inc. has a 52-week low of $17.23 and a 52-week high of $33.74. The business’s 50 day simple moving average is $27.60 and its two-hundred day simple moving average is $24.19. The firm has a market cap of $2.46 billion, a P/E ratio of 17.15 and a beta of 0.62.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The company reported $0.72 EPS for the quarter, beating the consensus estimate of $0.65 by $0.07. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The firm had revenue of $501.37 million during the quarter, compared to the consensus estimate of $498.18 million. During the same quarter in the previous year, the company posted $0.67 earnings per share. The company’s quarterly revenue was up 1.7% on a year-over-year basis. As a group, research analysts forecast that Pediatrix Medical Group, Inc. will post 2.21 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on MD shares. Jefferies Financial Group cut Pediatrix Medical Group from a “buy” rating to a “hold” rating and increased their price target for the stock from $27.00 to $28.00 in a report on Wednesday, August 19th. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 13th. Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, September 9th. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $28.00 to $31.00 and gave the company a “hold” rating in a research report on Friday, October 30th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $25.00 target price on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. One equities research analyst has rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $27.20.

Get Our Latest Report on Pediatrix Medical Group

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.

See Also

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.